163 related articles for article (PubMed ID: 32176040)
1. The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention.
Liu G; Yang S; Chen S
Medicine (Baltimore); 2020 Mar; 99(11):e19143. PubMed ID: 32176040
[TBL] [Abstract][Full Text] [Related]
2. [Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].
Fang L; Zhao Y; Wang N; Yang Z; Huang H; Lin M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):871-6. PubMed ID: 26663068
[TBL] [Abstract][Full Text] [Related]
3. CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.
McDonough CW; McClure LA; Mitchell BD; Gong Y; Horenstein RB; Lewis JP; Field TS; Talbert RL; Benavente OR; Johnson JA; Shuldiner AR
J Am Heart Assoc; 2015 May; 4(6):e001652. PubMed ID: 26019129
[TBL] [Abstract][Full Text] [Related]
4. CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study.
Lin J; Mo Y; Cai D; Mao D; Fu H; Wei D
Ann Palliat Med; 2021 Dec; 10(12):12171-12180. PubMed ID: 35016407
[TBL] [Abstract][Full Text] [Related]
5. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response.
Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF
CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
[TBL] [Abstract][Full Text] [Related]
7. Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel.
Qiu LN; Sun Y; Wang L; Han RF; Xia XS; Liu J; Li X
Eur J Pharmacol; 2015 Jan; 747():29-35. PubMed ID: 25489921
[TBL] [Abstract][Full Text] [Related]
8. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
[TBL] [Abstract][Full Text] [Related]
9. CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel.
Jeong TD; Kim SM; Kim HJ; Lee W; Kwon SU; Min WK; Kang DW; Chun S
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):440-6. PubMed ID: 25529343
[TBL] [Abstract][Full Text] [Related]
10. Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis.
Yan Y; Hao R; Zhao X; Xia X; Wang L; Li X
J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106798. PubMed ID: 36215918
[TBL] [Abstract][Full Text] [Related]
11. Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.
Sun W; Li Y; Li J; Zhang Z; Zhu W; Liu W; Cai Q; Wang X; Cao L; Bai W; Fan X; Ma M; Guo R; Liu X; Xu G
Platelets; 2015; 26(6):558-62. PubMed ID: 25207801
[TBL] [Abstract][Full Text] [Related]
12. Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel.
Wang Y; Cai H; Zhou G; Zhang Z; Liu X
J Neurol Sci; 2016 Oct; 369():216-219. PubMed ID: 27653892
[TBL] [Abstract][Full Text] [Related]
13. Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study.
Fu H; Hu P; Ma C; Peng F; He Z
Medicine (Baltimore); 2020 Apr; 99(15):e19472. PubMed ID: 32282698
[TBL] [Abstract][Full Text] [Related]
14. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
[TBL] [Abstract][Full Text] [Related]
15. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
[TBL] [Abstract][Full Text] [Related]
16. Ischemic stroke and myocardial ischemia in clopidogrel users and the association with CYP2C19 loss-of-function homozygocity: a real-world study.
Gronich N; Lavi I; Lejbkowicz F; Pinchev M; Zoabi Y; Auriel E; Saliba W; Rennert G
Pharmacogenomics J; 2021 Jun; 21(3):402-408. PubMed ID: 33649514
[TBL] [Abstract][Full Text] [Related]
17. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia.
Zhu WY; Zhao T; Xiong XY; Li J; Wang L; Zhou Y; Gong ZL; Cheng SY; Liu Y; Shuai J; Yang QW
Sci Rep; 2016 May; 6():25478. PubMed ID: 27137706
[TBL] [Abstract][Full Text] [Related]
19. Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients.
Li C; Jia W; Li J; Li F; Ma J; Zhou L
BMC Neurol; 2021 Mar; 21(1):104. PubMed ID: 33685396
[TBL] [Abstract][Full Text] [Related]
20. Analysis of
Pilling LC; Türkmen D; Fullalove H; Atkins JL; Delgado J; Kuo CL; Kuchel GA; Ferrucci L; Bowden J; Masoli JAH; Melzer D
BMJ Open; 2021 Dec; 11(12):e053905. PubMed ID: 34903548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
